Showing results (91-100 of 283) with videos related to
Sort By:
Pageof 29
Clinical Therapeutics|January 30, 2010
Drug-eluting stents and glycoprotein IIb/IIIa inhibitors in vessels at low anatomic risk: a retrospective analysis of previously published data from the Basel Stent Kosten Effektivitäts TrialRaban V Jeger, Hans Peter Brunner-La Rocca, Patrick R Hunziker, et al.American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 12, 2025
Cost-Effectiveness of Empagliflozin in Patients with Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the NetherlandsBart P H Slob, Maarten J Postma, Maaike Weersma, et al.European Heart Journal|November 27, 2008
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKETMatthias Pfisterer, Hans Peter Brunner-La Rocca, Peter Rickenbacher, et al.Journal of Hypertension|May 23, 2002
Divergent effects of ANP and BNP in acute heart failure: evidence for a putative BNP-selective receptor?Hans Peter Brunner-La Rocca, Robyn L Woods, David M Kaye, et al.European Journal of Heart Failure|July 2, 2025
Exploring safety of down-titrating diuretics in heart failure managementChrit B G Geraeds, Anke Bruninx, Andre L A J Dekker, et al.Journal of the American College of Cardiology|February 25, 2012
Coronary artery disease progression late after successful stent implantationMichael J Zellweger, Christoph Kaiser, Raban Jeger, et al.Hypertension (Dallas, Tex. : 1979)|November 2, 2002
Interaction of sildenafil with cAMP-mediated vasodilation in vivoChristoph Schalcher, Karin Schad, Hans Peter Brunner-La Rocca, et al.European Journal of Heart Failure|March 16, 2017
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF)Peter Rickenbacher, Beat A Kaufmann, Micha T Maeder, et al.Lancet (London, England)|November 6, 2007
Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysisHans Peter Brunner-La Rocca, Christoph Kaiser, Alain Bernheim, et al.European Heart Journal. Cardiovascular Imaging|October 31, 2021
The prognostic impact of mechanical atrial dysfunction and atrial fibrillation in heart failure with preserved ejection fractionJerremy Weerts, Arantxa Barandiarán Aizpurua, Michiel T H M Henkens, et al.Pageof 29